日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Loss of BCL7A permits IRF4 transcriptional activity and cellular growth in multiple myeloma.

BCL7A 的缺失使得 IRF4 转录活性增强,并促进多发性骨髓瘤细胞的生长。

Chakraborty Chandraditya, Talluri Srikanth, Binder Moritz, Morelli Eugenio, Mayoral Jessica Encinas, Derebail Sanika, Samur Anil Aktas, Epstein Charles, Anderson Kenneth C, Shammas Masood, Samur Mehmet K, Fulciniti Mariateresa, Munshi Nikhil C

Immune profiling of smoldering multiple myeloma patients treated in a phase lb study of PVX-410 vaccine targeting XBP1/CD138/CS1 antigens, and citarinostat, a histone deacetylase inhibitor (HDACi) with and without lenalidomide

本研究对接受PVX-410疫苗(靶向XBP1/CD138/CS1抗原)和西他诺司他(一种组蛋白去乙酰化酶抑制剂,HDACi)联合或不联合来那度胺治疗的冒烟型多发性骨髓瘤患者进行了Ib期临床试验,并分析了接受西他诺司他治疗的冒烟型多发性骨髓瘤患者的免疫特征。

Cirstea, Diana; Shome, Rajib; Samur, Mehmet; Talluri, Srikanth; Connolly, Joseph J; Wright, Alexandra Jean; Duvallet, Emilie; Joyce, Amanda N R; Lively, Kathleen; Basinsky, Gina; Yee, Andrew J; Chase, Cristiana Costa; Malek, Ehsan; Niesvizky, Ruben; Richardson, Paul G; Raje, Noopur S

Pomalidomide improved immune profiles in myeloma

泊马度胺改善了多发性骨髓瘤的免疫功能

Seah, Hannah; Bade, Vaishnavi Reddy; Potluri, Lakshmi Bhavani; Talluri, Srikanth; Prabhala, Rao H

Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myeloma

GABARAP 的缺失介导多发性骨髓瘤对免疫原性化疗的耐药性

Gulla, Annamaria; Morelli, Eugenio; Johnstone, Megan; Turi, Marcello; Samur, Mehmet K; Botta, Cirino; Cifric, Selma; Folino, Pietro; Vinaixa, Delaney; Barello, Francesca; Clericuzio, Cole; Favasuli, Vanessa Katia; Maisano, Domenico; Talluri, Srikanth; Prabhala, Rao; Bianchi, Giada; Fulciniti, Mariateresa; Wen, Kenneth; Kurata, Keiji; Liu, Jiye; Penailillo, Johany; Bragoni, Alberto; Sapino, Anna; Richardson, Paul G; Chauhan, Dharminder; Carrasco, Ruben D; Hideshima, Teru; Munshi, Nikhil C; Anderson, Kenneth C

Bone marrow stromal cells induce chromatin remodeling in multiple myeloma cells leading to transcriptional changes.

骨髓基质细胞诱导多发性骨髓瘤细胞染色质重塑,导致转录改变

Binder Moritz, Szalat Raphael E, Talluri Srikanth, Fulciniti Mariateresa, Avet-Loiseau Hervé, Parmigiani Giovanni, Samur Mehmet K, Munshi Nikhil C

Elevated APE1 Dysregulates Homologous Recombination and Cell Cycle Driving Genomic Evolution, Tumorigenesis, and Chemoresistance in Esophageal Adenocarcinoma

APE1 表达升高会扰乱同源重组和细胞周期,从而驱动食管腺癌的基因组进化、肿瘤发生和化疗耐药性。

Kumar, Subodh; Zhao, Jiangning; Talluri, Srikanth; Buon, Leutz; Mu, Shidai; Potluri, Lakshmi B; Liao, Chengcheng; Shi, Jialan; Chakraborty, Chandraditya; Gonzalez, Gabriel B; Tai, Yu-Tzu; Patel, Jaymin; Pal, Jagannath; Mashimo, Hiroshi; Samur, Mehmet K; Munshi, Nikhil C; Shammas, Masood A

Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics

鉴定骨髓瘤中与疾病相关的异常剪接转录本,并制定基于RNA的疗法靶向这些改变的策略

Ogiya, Daisuke; Chyra, Zuzana; Verselis, Sigitas J; O'Keefe, Morgan; Cobb, Jacquelyn; Abiatari, Ivane; Talluri, Srikanth; Sithara, Anjana Anilkumar; Hideshima, Teru; Chu, Michael P; Hájek, Roman; Dorfman, David M; Pilarski, Linda M; Anderson, Kenneth C; Adamia, Sophia

Integrated genomics and comprehensive validation reveal drivers of genomic evolution in esophageal adenocarcinoma

整合基因组学和全面验证揭示了食管腺癌基因组进化的驱动因素

Kumar, Subodh; Buon, Leutz; Talluri, Srikanth; Roncador, Marco; Liao, Chengcheng; Zhao, Jiangning; Shi, Jialan; Chakraborty, Chandraditya; Gonzalez, Gabriel; Tai, Yu-Tzu; Prabhala, Rao; Samur, Mehmet K; Munshi, Nikhil C; Shammas, Masood A

RAD51 Inhibitor Reverses Etoposide-Induced Genomic Toxicity and Instability in Esophageal Adenocarcinoma Cells

RAD51抑制剂逆转依托泊苷诱导的食管腺癌细胞基因组毒性和不稳定性

Liao, Chengcheng; Zhao, Jiangning; Kumar, Subodh; Chakraborty, Chandraditya; Talluri, Srikanth; Munshi, Nikhil C; Shammas, Masood A

Institutional Experience of Microsurgical Management in Posterior Circulation Aneurysm

后循环动脉瘤显微外科治疗的机构经验

Sharma, Raghavendra Kumar; Kumar, Ambuj; Yamada, Yasuhiro; Tanaka, Riki; Sharma, Saurabh; Miyatani, Kyosuke; Higashiguchi, Saeko; Kawase, Tsukasa; Talluri, Srikanth; Kato, Yoko